AbbVie Inc. (ABBV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 25B 50B 75B Q3 '24: 55.5B Q4 '24: 56.3B Q1 '25: 57.4B Q2 '25: 58.3B Q3 '25: 59.6B Q4 '25: 61.2B Q1 '26: 62.8B Q2 '26: 64.4B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 9B 18B 27B Q1 '18: 22.3B Q2 '18: 23.2B Q3 '18: 24.2B Q4 '18: 25B Q1 '19: 25.2B Q2 '19: 25.3B Q3 '19: 25.4B Q4 '19: 25.8B Q1 '18 Q2 '18 Q3 '18 Q4 '18 Q1 '19 Q2 '19 Q3 '19 Q4 '19

Operating Income TTM

0 6B 12B 18B Q3 '23: 15.1B Q4 '23: 12.8B Q1 '24: 12.8B Q2 '24: 12.3B Q3 '24: 13.8B Q4 '25: 15.1B Q1 '26: 15.3B Q2 '26: 16.9B Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

0 2.5B 5B 7.5B Q3 '24: 5.1B Q4 '24: 4.3B Q1 '25: 4.2B Q2 '25: 3.8B Q3 '25: 2.4B Q4 '25: 4.2B Q1 '26: 3.6B Q2 '26: 6.3B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 7B 14B 21B Q3 '24: 18.2B Q4 '24: 16.9B Q1 '25: 16.8B Q2 '25: 17B Q3 '25: 18B Q4 '25: 18.2B Q1 '26: 18.4B Q2 '26: 18.4B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 8B 16B 24B Q3 '24: 16.5B Q4 '24: 18.8B Q1 '25: 16.4B Q2 '25: 19.3B Q3 '25: 20.9B Q4 '25: 19B Q1 '26: 21.2B Q2 '26: 19.5B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

0 7B 14B 21B Q3 '24: 15.6B Q4 '24: 17.8B Q1 '25: 15.4B Q2 '25: 18.2B Q3 '25: 19.7B Q4 '25: 17.8B Q1 '26: 20B Q2 '26: 18.2B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 700M 1.4B 2.1B Q1 '24: 1.8B Q2 '24: 1.8B Q3 '24: 1.8B Q1 '25: 1.8B Q2 '25: 1.8B Q3 '25: 1.8B Q1 '26: 1.8B Q2 '26: 1.8B Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q3 '24: 2.88 Q4 '24: 2.40 Q1 '25: 2.35 Q2 '25: 2.10 Q3 '25: 1.32 Q4 '25: 2.36 Q1 '26: 2.03 Q2 '26: 3.54 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.